SARMSARM

ACP-105

SARM

Also known as ACP105, acp 105

Half-life

~6-8 hours

What is ACP-105?

Investigational nonsteroidal SARM studied for anabolic selectivity.

How ACP-105 works

Selective AR modulation targeting muscle and bone with lower androgenic tissue activation than testosterone.

Benefits & uses

Lean muscle/strength
Reported milder androgenic profile
Cognitive/neuroprotective interest (early)

Common uses: Lean muscle, strength (experimental).

ACP-105 dosage

Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports — dosing should be set with a qualified clinician.

Protocol notes: 10-15mg daily. Mild SARM, good for first cycle or females. Less suppressive.
Commonly reported: Observational: ~20–30 mg/day (limited data)Observational use reports — not a recommendation.

ACP-105 half-life

~6-8 hours (estimated)

ACP-105 side effects

Suppression risk
Headache/nausea
Sparse human data
Testosterone suppression
Lipid shift
Limited data

Warnings & monitoring

Limited human data — experimental. Requires bloodwork + medical guidance
Suppressive — PCT may be needed
FDA-warned / WADA-banned / gray-market
Not approved for human use

Commonly stacked with

Ostarine (MK-2866)Cardarine (GW-501516)

Track ACP-105 in Protokol.

Log doses, model half-lives, check interactions, and line it all up against your bloodwork. Free on iPhone and Android.